ILMN

Illumina Inc

May 15 • 04:00PM ET

142.54

-0.70 -0.49 %

Healthcare • Diagnostics & Research • USA • Large • NASD

Peers: QGEN TXG PACB NTRA GH RVTY DHR TECH TMO BIO

| Held by: IJH VTI VB VBR VXF XMHQ MDY ARKK IBB SPMD

Index	-	P/E	25.87	EPS (ttm)	5.51	Insider Own	2.77%	Shs Outstand	152.00M	Perf Week	0.47%
Market Cap	21.57B	Forward P/E	24.09	EPS next Y	5.92	Insider Trans	-7.39%	Shs Float	147.09M	Perf Month	7.40%
Enterprise Value	22.96B	PEG	2.03	EPS next Q	1.23	Inst Own	104.53%	Short Float	4.45%	Perf Quarter	22.03%
Income	853.00M	P/S	4.91	EPS this Y	7.88%	Inst Trans	1.43%	Short Ratio	3.84	Perf Half Y	16.86%
Sales	4.39B	P/B	8.10	EPS next Y	13.31%	ROA	13.39%	Short Interest	6.55M	Perf YTD	8.68%
Book/sh	17.61	P/C	18.67	EPS next 5Y	11.89%	ROE	33.82%	52W High	155.53 -8.35%	Perf Year	76.19%
Cash/sh	7.63	P/FCF	22.14	EPS past 3/5Y	- 4.22%	ROIC	18.38%	52W Low	78.55 81.46%	Perf 3Y	-28.40%
Dividend Est.	-	EV/EBITDA	19.54	Sales past 3/5Y	-1.82% 6.02%	Gross Margin	67.14%	Volatility	4.15% 4.31%	Perf 5Y	-61.51%
Dividend TTM	-	EV/Sales	5.23	EPS Y/Y TTM	191.21%	Oper. Margin	20.59%	ATR (14)	5.85	Perf 10Y	7.12%
Dividend Ex-Date	-	Quick Ratio	1.36	Sales Y/Y TTM	1.25%	Profit Margin	19.43%	RSI (14)	60.52	Recom	2.22
Dividend Gr. 3/5Y	- -	Current Ratio	1.75	EPS Q/Q	5.61%	SMA20	5.29%	Beta	1.46	Target Price	143.83
Payout	0.00%	Debt/Eq	0.95	Sales Q/Q	4.80%	SMA50	10.52%	Rel Volume	1.04	Prev Close	143.24
Employees	8600	LT Debt/Eq	0.73	Earnings	Apr 30 AMC	SMA200	18.82%	Avg Volume	1.71M	Price	142.54
IPO	Jul 28, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.06% 1.66%	Trades		Volume	1,770,123	Change	-0.49%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-26	Resumed	RBC Capital Mkts	Outperform	$170
May-14-26	Upgrade	Daiwa Securities	Neutral → Outperform	$155
Aug-12-25	Downgrade	Daiwa Securities	Outperform → Neutral	$94
Jul-11-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$125
Mar-04-25	Reiterated	Citigroup	Neutral	$130 → $90
Feb-28-25	Downgrade	HSBC Securities	Buy → Hold	$100
Feb-10-25	Downgrade	Barclays	Equal Weight → Underweight	$130 → $100
Feb-07-25	Downgrade	TD Cowen	Buy → Hold	$177 → $140
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185

Show Previous Ratings

May-15-26 09:45AM	Cisco upgraded, Doximity downgraded: Wall Street's top analyst calls (The Fly)
12:01AM	Nateras Stronghold in Cancer Recurrence Tests Prompts Woods Ark to Expand Stake (The Daily Upside)
May-11-26 03:34PM	Musk, Cook Expected to Join Trump for Xi Summit in China (Bloomberg)
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-01-26 08:30AM	Illumina, Inc. Q1 2026 Earnings Call Summary (Moby) +7.13%
03:17AM	Loading…
03:17AM	Illumina Inc (ILMN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Apr-30-26 04:36PM	Illumina: Q1 Earnings Snapshot (Associated Press) +5.29%
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 (PR Newswire)
Apr-16-26 09:15AM	DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows (PR Newswire)
Apr-14-26 09:15AM	Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease (PR Newswire)
Apr-09-26 04:30PM	Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 (PR Newswire)
Apr-02-26 09:07AM	Illumina Announces Changes to Board of Directors (PR Newswire)
Mar-18-26 09:15AM	Illumina and Labcorp expand collaboration to broaden access to precision oncology testing (PR Newswire)
Mar-16-26 09:15AM	Illumina advances preventive genomics through strategic consortium with Veritas Genetics (PR Newswire)
Mar-09-26 09:50AM	Here's Why Illumina (ILMN) is a Strong Momentum Stock (Zacks)
09:40AM	Loading…
Mar-06-26 09:40AM	Here's Why Illumina (ILMN) is a Strong Value Stock (Zacks)
Mar-05-26 09:15AM	Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering (PR Newswire)
08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 09:45AM	Why Illumina (ILMN) is a Top Growth Stock for the Long-Term (Zacks)
Mar-03-26 10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Mar-02-26 05:32PM	Quanterix Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 09:15AM	Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida (PR Newswire) +5.54%
Feb-26-26 10:48AM	TEM vs. ILMN: Which MedTech Stock Offers Greater Upside? (Zacks)
Feb-25-26 09:15AM	Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics (PR Newswire)
Feb-24-26 12:15PM	Illumina launches TruPath Genome, setting a new standard in genomic insight (PR Newswire)
Feb-23-26 09:15AM	Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility (PR Newswire)
Feb-20-26 04:26PM	This once-hot cancer-detection company's stock got cut in half after a failed trial (MarketWatch)
10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
12:00AM	GRAIL Inc (GRAL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Challenges (GuruFocus.com)
Feb-18-26 09:40AM	Why Illumina (ILMN) is a Top Value Stock for the Long-Term (Zacks)
06:02AM	Loading…
06:02AM	The Quality Screened Mid Cap XMHQ ETF Rocketed 283% And Made Money The Easy Way (24/7 Wall St.)
Feb-17-26 03:10PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
Feb-12-26 10:00AM	Devyser Diagnostics AB (FRA:OL0) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
09:45AM	Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
08:24AM	Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips (Zacks)
12:36AM	5 Insightful Analyst Questions From Illumina's Q4 Earnings Call (StockStory)
Feb-09-26 11:19AM	Waters Q4 Earnings Call Highlights (MarketBeat)
09:15AM	Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects (Zacks)
Feb-06-26 01:25PM	Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? (Benzinga) -10.40%
03:48AM	Analyst Report: Illumina, Inc. (Morningstar Research)
12:36AM	ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum (StockStory)
12:05AM	Illumina Inc (ILMN) Q4 2025 Earnings Call Highlights: Strong Clinical Growth Amidst Research ... (GuruFocus.com)
Feb-05-26 08:58PM	Illumina Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:00PM	Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:59PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:17PM	Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 (StockStory)
04:06PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 (PR Newswire)
Feb-04-26 09:15AM	Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics (Zacks)
Feb-03-26 10:18PM	Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
06:15PM	Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:15AM	Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo, supporting critical conservation genetics efforts globally (PR Newswire)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Feb-02-26 09:37AM	ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance (Zacks)
12:47AM	Grail files for FDA approval of multi-cancer early detection test (MedTech Dive)
Jan-30-26 10:00AM	Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:05AM	Illumina completes acquisition of SomaLogic (PR Newswire)
Jan-29-26 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-27-26 08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jan-24-26 12:01PM	The Most Expensive Question Investors Ask (Barchart)
Jan-23-26 11:40AM	REGN or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
Jan-21-26 10:31PM	Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest (StockStory)
04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
Jan-20-26 01:19PM	Illumina Gets Medicare Boost for Cancer Test, Shares Climb (Benzinga)
09:15AM	Illumina secures CMS reimbursement for TruSight Oncology Comprehensive, expanding access to precision oncology (PR Newswire)
04:58AM	Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside (Insider Monkey)
12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga)
Jan-16-26 02:22AM	The clinical candidates pharma execs are tracking (Pharma Voice)
Jan-15-26 08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-13-26 04:58PM	Illumina CEO Sees Big Growth Opportunity in China (Bloomberg)
01:01PM	JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery (Pharmaceutical Technology)
12:37PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:15AM	Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery (PR Newswire)
09:00AM	Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 (PR Newswire)
07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks)
Jan-12-26 04:07PM	Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 (PR Newswire)
11:34AM	Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab (Yahoo Finance)
08:09AM	Illumina's New Connected Multiomics Platform Set to Boost Its Stock (Zacks)
Jan-09-26 12:10PM	Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-08-26 04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
04:30PM	Illumina Appoints Dr. Eric Green as Chief Medical Officer (PR Newswire)
Jan-07-26 11:40AM	REGN vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
07:33AM	TEM's Stable Solvency and Financial Strength Are Gaining Attention (Zacks)
Jan-06-26 07:48PM	Analyst Report: Illumina, Inc. (Morningstar Research)
11:40AM	REGN vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
09:15AM	Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis (PR Newswire)
07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
Dec-31-25 09:50AM	Here's Why Illumina (ILMN) is a Strong Momentum Stock (Zacks)
01:30AM	It's Earnings Warning Season. How to Profit From Others' Misery. (Barrons.com)
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-26-25 07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:18AM	How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

CEOMr. Jacob Thaysen Ph.D.

Chief Financial OfficerMr. Ankur Dhingra CPA

Chief Technology OfficerDr. Steven Barnard Ph.D.

Chief Information OfficerMr. Mark Field

VP of Investor RelationsMr. Conor Noel McNamara C.F.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Meister Keith A.	Director	May 13 '26	Sale	145.55	225,067	32,759,594	3,604,441	May 14 07:21 PM
Meister Keith A.	Director	May 14 '26	Sale	145.34	104,393	15,172,381	3,500,048	May 14 07:21 PM
Corvex Management LP	Affiliate of Director (1)	May 13 '26	Proposed Sale	145.70	600,000	87,420,000		May 13 05:36 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	May 06 '26	Sale	139.04	700	97,328	15,056	May 07 06:20 PM
JAKOB WEDEL	Officer	May 06 '26	Proposed Sale	139.04	700	97,328		May 06 04:10 PM
Davies Scott M	Chief Legal Officer	Feb 20 '26	Sale	116.18	1,336	155,216	16,334	Feb 24 04:11 PM
SCOTT DAVIES	Officer	Feb 20 '26	Proposed Sale	120.00	1,336	160,320		Feb 20 04:28 PM
Leckman Patricia	SVP, Chief People Officer	Feb 18 '26	Sale	116.18	2,370	275,347	16,321	Feb 18 04:49 PM
PATRICIA L LECKMAN	Officer	Feb 18 '26	Proposed Sale	116.18	2,370	275,347		Feb 18 04:22 PM
Barnard Steven	SVP, Chief Technology Officer	Feb 12 '26	Option Exercise	0.00	2,677	0	35,708	Feb 17 04:55 PM
Thaysen Jacob	Chief Executive Officer	Feb 12 '26	Option Exercise	0.00	13,264	0	95,353	Feb 17 04:53 PM
Pegels Kevin Carl	Chief of Global Operations	Feb 12 '26	Option Exercise	0.00	2,283	0	24,759	Feb 17 04:48 PM
Davies Scott M	Chief Legal Officer	Feb 12 '26	Option Exercise	0.00	1,370	0	19,257	Feb 17 04:46 PM
Leckman Patricia	SVP, Chief People Officer	Feb 12 '26	Option Exercise	0.00	1,028	0	20,419	Feb 17 04:45 PM
Ericksen Scott D	VP, Chief Accounting Officer	Feb 12 '26	Option Exercise	0.00	743	0	14,229	Feb 17 04:44 PM
Gottlieb Scott	Director	Feb 09 '26	Buy	117.81	200	23,562	12,723	Feb 11 04:04 PM
Davies Scott M	Chief Legal Officer	Dec 12 '25	Sale	136.09	323	43,957	17,887	Dec 16 05:00 PM
SCOTT DAVIES	Officer	Dec 12 '25	Proposed Sale	136.09	323	43,957		Dec 12 04:09 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	Dec 08 '25	Sale	129.27	549	70,969	10,952	Dec 09 04:15 PM
JAKOB WEDEL	Officer	Dec 08 '25	Proposed Sale	129.27	549	70,969		Dec 08 04:31 PM
ILLUMINA, INC.	10% Owner	Nov 17 '25	Sale	79.85	1,000,000	79,850,000	3,502,126	Nov 18 09:33 PM
SCOTT DAVIES	Officer	Nov 12 '25	Proposed Sale	122.79	323	39,661		Nov 12 04:05 PM
Gottlieb Scott	Director	Nov 03 '25	Buy	122.13	500	61,065	12,523	Nov 05 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your Finviz experience